Holen Sie sich die Stockscreener-App
2.43
0.41%
-0.010
Aclarion Inc Aktie (ACON) Neueste Nachrichten
ACON Q2 2026 Earnings: Wider -$1.12 Per-Share Loss Sends Shares Down 4.76%Negative Surprise Momentum - vinanet.vn
Aclarion Inc (ACONW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Aclarion (ACONW) Stock: Holds Near $0.03 in the Latest Reading; Chart View - vinanet.vn
Aclarion (ACON) Outlook: Moves 0.74% Higher to $2.71 on the Day; Price Setup: Traders Can Monitor the $2.57-$2.85 Range in Latest TradingIndex Put Call - vinanet.vn
Aclarion (ACON) Upgraded to Buy: Here's Why - Eastern Progress
Aclarion, Inc. Revenue Breakdown – NASDAQ:ACON - TradingView
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - Orthopedics This Week
AclarionAnticipates Having Initial Interna - Moomoo
Aclarion adds University of Arizona to Nociscan spine trial By Investing.com - Investing.com Australia
Aclarion adds University of Arizona to Nociscan spine trial - Investing.com
Aclarion Announces Addition of University of Arizona College of MedicinePhoenix as CLARITY Trial Site - The Manila Times
Aclarion's 300-patient back-pain study now has 10 enrolling sites - Stock Titan
Aclarion (ACON) EPS and Revenue: The Available Earnings Metric Delivers a Miss in Latest Trading; After Results: The Stock Gains 6.54% on the DayROIC Trend Report - vinanet.vn
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Amanda Williams buys $15,989 in common stock - Investing.com
Top Aclarion Executive Makes Bold Insider Move on Company Stock - TipRanks
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com Nigeria
Aclarion (ACON) Earnings Numbers in Focus: EPS Comes in Below Forecast under the Current Snapshot; Investor Response: The Market Price Declines 6.14% on the DayHealthcare Earnings Report - vinanet.vn
ACON | Aclarion, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock - Investing.com
Major Insider Buying Spree Signals Strong Confidence in This Tech Stock - TipRanks
Aclarion director William Wesemann buys $5,031 in company stock By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Ryan Bond buys $50,059 in ACON shares By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock - Investing.com
Aclarion director William Wesemann buys $5,031 in company stock - Investing.com
Aclarion director Ryan Bond buys $50,059 in ACON shares - Investing.com
Aclarion (ACON) director lifts stake to 23,713 shares - Stock Titan
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeNarrow Range Breakout - dars.gov.et
Aclarion receives patent allowance for MRI scan technology By Investing.com - Investing.com Nigeria
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process - The Manila Times
Aclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc Evaluation - Quiver Quantitative
Aclarion receives patent allowance for MRI scan technology - Investing.com
Aclarion Inc. (ACON) Slips 3.39% as Shares Approach Key $2.17 SupportCall Dominated - dars.gov.et
Aclarion, Inc. Revenue Breakdown – FWB:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – BOATS:ACONW - TradingView
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Aclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - TradingView
Aclarion (NASDAQ: ACON) posts $5.6M H1 loss, holds $16.3M cash - Stock Titan
Aclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208 - Bitget
Aclarion Inc. Warrant (ACONW) Slips 2.39% but Remains Supported at $0.02Resistance Breakout Stocks - dars.gov.et
Aclarion (ACON) Slips 1.69% to $2.32: Stock Presses Against Support at $2.20Strong Buy Stocks - dars.gov.et
Aclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver Quantitative
Aclarion, Inc Announces Nociscan Now Available At Goodman Campbell Brain & Spine At Ascension St. Vincent - marketscreener.com
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology - Barchart.com
Aclarion Inc. Warrant (ACONW) Surges 35% to $0.03, Trading at Critical JunctureETF Inflow Streak - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds at $0.02 as Trading Range Compresses to a PointFibonacci Retracement - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds Steady at $0.02 as Trading Range CompressesNew Listing Stocks - dars.gov.et
ACON Q1 2026 Earnings: EPS Exceeds Estimates by 15.2%, Shares Rise 11.4%Earnings Deceleration Risk - vinanet.vn
Aclarion Inc. Warrant (ACONW) Flat at $0.02 as Support and Resistance ConvergeBuy Signal Reports - dars.gov.et
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026 - Orthopedics This Week
Aclarion reports 141% scan volume growth in first half of 2026 - Investing.com Nigeria
0.02%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):